Selegiline use is associated with a slower progression in early Parkinson’s disease as evaluated by Hoehn and Yahr Stage transition times
2011 ◽
Vol 17
(3)
◽
pp. 194-197
◽
Keyword(s):
2011 ◽
Vol 17
(4)
◽
pp. 299-300
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):